An Undetected Expansion, Spread, and Burden of Chikungunya and Dengue Cocirculating Antibodies in Nigeria
Open Access
- 12 August 2024
- journal article
- research article
- Published by MDPI AG in Zoonotic Diseases
- Vol. 4 (3) , 201-213
Abstract
Chikungunya and dengue are arboviral diseases transmitted by mosquitoes that have been increasingly recognized as public health concerns in Sub-Saharan Africa. Several studies conducted in Nigeria and other West African countries have revealed the seroprevalence burden and cocirculation of antibodies against mosquito-borne infections, thereby revealing a significant burden and clinical outcome complexities that have largely gone undetected. The current research study has important implications for disease surveillance, prevention strategies, and healthcare planning in Nigeria and other Sub-Saharan countries. A cross-sectional study was conducted on 871 outpatients and pregnant women from three regions of Nigeria. CHIKV and DENV immunoblot molecular diagnostic assays were used to analyze the serum samples for the presence of arboviral antibody serological markers IgG (Mikrogen Diagnostik, Germany) with DENV nonstructural protein 1 and DENV Equad and CHIKV virus-like particles (VLPs), according to the manufacturer’s instructions. A total of 871 participants were recruited from three geographical regions in Nigeria. Among them, 17.5% (152/871) were from Abia (southern Nigeria), 34.4% (300/871) were from Kaduna (northern Nigeria), and 48.1% (419/871) were from Nasarawa (central Nigeria). The ages of the participants ranged from 0 months to 80 years, with a mean age of 36.6 years. Of the 871 subjects, 71.0% (619/871) were female, and 29.0% (252/871) were male. The overall cohort detectable antibody seropositivity against CHIKV was 64.9% (565/871), 95% CI (61.74–68.06); DENV, 44.7% (389/871), 95% CI (41.41–47.99); and CHIKV-DENV cocirculation antibodies, 31.6% (95% CI 29–35). This study highlighted the unpredictably high seroprevalence, expansion, magnitude, and undetected burden of chikungunya and dengue in Nigeria.Keywords
Funding Information
- World Health Organization (1013487-0)
This publication has 27 references indexed in Scilit:
- Diagnosis of Chikungunya Virus in Febrile Patients From a Malaria Holoendemic AreaInternational Journal of Infectious Diseases, 2021
- Detection of coinfection with Chikungunya virus and Dengue virus serotype 2 in serum samples of patients in State of Tocantins, BrazilJournal of Infection and Public Health, 2020
- Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of NigeriaThe Brazilian Journal of Infectious Diseases, 2020
- Dengue haemorrhagic fever: An emerging disease in Nigeria, West AfricaJournal of Infection and Public Health, 2018
- Current concerns and perspectives on Zika virus co-infection with arboviruses and HIVJournal of Autoimmunity, 2018
- Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary AssessmentImmunological Investigations, 2017
- Dengue virus non-structural Protein-1 expression and associated risk factors among febrile Patients attending University of Abuja Teaching Hospital, NigeriaVirus Research, 2017
- A survey of malaria and some arboviral infections among suspected febrile patients visiting a health centre in Simawa, Ogun State, NigeriaJournal of Infection and Public Health, 2016
- Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolatesVirus Research, 2008
- Chikungunya Outbreaks — The Globalization of Vectorborne DiseasesNew England Journal of Medicine, 2007